There are very less trials and data on it.
Also it is effective against very less bacteria.
And they are very specific to the organism so there has to be a culture report first before starting it.
Cost of any new upcoming therapy is very high same is with this.
Also machinery availability is an issue
And guidelines are obscure due to lack of proper data.
I hope that answers your question.
Answered2021-03-09 04:36:35
1/1 people found this helpful